Remove tag joint-working
article thumbnail

FDA begins review of Samsung Bioepis/Biogen’s Lucentis biosimilar

pharmaphorum

But it has been a source of controversy – it works by attacking the rogue blood vessels that build up in the retina that are the root cause of wet AMD, something that Roche’s Avastin (bevacizumab) cancer drug can do in an off-label use at a fraction of the price.

FDA 64
article thumbnail

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

pharmaphorum

Access to medicines is “one of the most challenging policy areas in every country in the European region” – it’s time to develop a solution that works for everyone. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model. About the author.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A history of Pfizer

pharmaphorum

This caused Pfizer to change its tactics, and instead the company ended up signing a deal with GSK to combine the two companies’ consumer health businesses and form a joint venture with combined annual sales of $12.7 For all the latest Pfizer news follow pharmaphorum’s Pfizer tag.

article thumbnail

Tramadol (Ultram) alternatives: What can I take instead of tramadol?

The Checkup by Singlecare

Belbuca is a good alternative to opioid treatment that needs to be taken around the clock, but it may come with a hefty price tag. The gel may work as well as oral NSAIDs for arthritis pain and acute musculoskeletal pain (like sprains and strains). mg to 2 mg every 4 hours as needed—adjust according to response IM, SubQ: 0.2

article thumbnail

Developing point-of-care CAR T manufacturing

European Pharmaceutical Review

This is in addition to its considerable price tag. 11 These initial findings were further developed by industry; in many instances pharma companies provided funding while working hand-in-hand with academia to advance the field, benefitting patients. Hayden PJ et al. Annals of Oncology. 2022;33(3):259–75.